Acute liver failure resident survival guide

Revision as of 18:23, 9 December 2013 by Vendhan Ramanujam (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]

Definitions

Acute Liver Failure

Evidence of coagulation abnormality (INR ≥1.5) and any degree of alteration in mental status in the absence of pre exisiting chronic liver disease, cirrhosis and any illness of <26 weeks duration is defined as acute liver failure.[1][2] Few exceptions that are included in spite of their presentation with cirrhosis are Wilson disease, vertically-acquired HBV, and autoimmune hepatitis if they have been recognized for <26 weeks. When the above presentation duration is up to 26 weeks, acute liver failure is the better terminology to be used when compared to terms like fulminant hepatic failure, fulminant hepatitis or necrosis, hyperacute, acute and subacute liver failure.

Hepatic Encephalopathy

Based on their clinical manifestation, different grades of hepatic encephalopathy are defined as follows[3]

Grades Clinical Features
I Changes in behavior, minimal changes in level of consciousness
II Inappropriate behavior, gross disorientation, drowsiness, possibly asterixis
III Marked confusion, incoherent speech, mostly sleeping but arousable to vocal stimuli
IV Comatose, unresponsive to pain, decorticate or decerebrate posturing

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes


Do's

Dont's

References

  1. Trey, C.; Davidson, CS. (1970). "The management of fulminant hepatic failure". Prog Liver Dis. 3: 282–98. PMID 4908702.
  2. Polson, J.; Lee, WM. (2005). "AASLD position paper: the management of acute liver failure". Hepatology. 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455. Unknown parameter |month= ignored (help)
  3. Conn, HO.; Leevy, CM.; Vlahcevic, ZR.; Rodgers, JB.; Maddrey, WC.; Seeff, L.; Levy, LL. (1977). "Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial". Gastroenterology. 72 (4 Pt 1): 573–83. PMID 14049. Unknown parameter |month= ignored (help)
  4. Campos Franco, J.; Martínez Rey, C.; Pérez Becerra, E.; González Quintela, A. (2002). "[Cocaine related fulminant liver failure]". An Med Interna. 19 (7): 365–7. PMID 12224146. Unknown parameter |month= ignored (help)
  5. Lee, WM. (2008). "Etiologies of acute liver failure". Semin Liver Dis. 28 (2): 142–52. doi:10.1055/s-2008-1073114. PMID 18452114. Unknown parameter |month= ignored (help)
  6. Erden, A.; Esmeray, K.; Karagöz, H.; Karahan, S.; Gümüşçü, HH.; Başak, M.; Cetinkaya, A.; Avcı, D.; Poyrazoğlu, OK. (2013). "Acute liver failure caused by mushroom poisoning: a case report and review of the literature". Int Med Case Rep J. 6: 85–90. doi:10.2147/IMCRJ.S53773. PMID 24294010.
  7. 7.0 7.1 Bynum, TE.; Boitnott, JK.; Maddrey, WC. (1979). "Ischemic hepatitis". Dig Dis Sci. 24 (2): 129–35. PMID 428301. Unknown parameter |month= ignored (help)
  8. Ostapowicz, G.; Fontana, RJ.; Schiødt, FV.; Larson, A.; Davern, TJ.; Han, SH.; McCashland, TM.; Shakil, AO.; Hay, JE. (2002). "Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States". Ann Intern Med. 137 (12): 947–54. PMID 12484709. Unknown parameter |month= ignored (help)
  9. Gill, RQ.; Sterling, RK. (2001). "Acute liver failure". J Clin Gastroenterol. 33 (3): 191–8. PMID 11500606. Unknown parameter |month= ignored (help)
  10. Uemoto, S.; Inomata, Y.; Sakurai, T.; Egawa, H.; Fujita, S.; Kiuchi, T.; Hayashi, M.; Yasutomi, M.; Yamabe, H. (2000). "Living donor liver transplantation for fulminant hepatic failure". Transplantation. 70 (1): 152–7. PMID 10919593. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources